BCL2 and hepatocellular carcinoma: Most studies have shown that the expression of anti-apoptotic members such as Bcl-2 and Bcl-XL is elevated in tumor tissues of HCC patients (Hosseini-Khah et al., 2021; Y. YangZhu et al., 2011; Watanabe et al., 2004).